BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30459216)

  • 21. Human papilloma virus vaccine--more than a vaccine.
    Pallecaros A; Vonau B
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):541-6. PubMed ID: 18007131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus vaccine coverage.
    Yuji K; Matsumura T; Miyano S; Tsuchiya R; Kami M
    Lancet; 2010 Jul; 376(9738):329-30; author reply 330. PubMed ID: 20674715
    [No Abstract]   [Full Text] [Related]  

  • 23. Status of HPV vaccine introduction and barriers to country uptake.
    Gallagher KE; LaMontagne DS; Watson-Jones D
    Vaccine; 2018 Aug; 36(32 Pt A):4761-4767. PubMed ID: 29580641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus vaccine coverage.
    Desai S; Soldan K; White J; Sheridan A; Gill ON
    Lancet; 2010 Jul; 376(9738):328-9; author reply 330. PubMed ID: 20674714
    [No Abstract]   [Full Text] [Related]  

  • 25. New vaccines and screening can reduce cervical cancer incidence in poor countries.
    Watson R
    BMJ; 2008 Sep; 337():a1545. PubMed ID: 18768548
    [No Abstract]   [Full Text] [Related]  

  • 26. Implementation of human papillomavirus immunization in the developing world.
    Kane MA; Serrano B; de Sanjosé S; Wittet S
    Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccination against human papilloma virus. Has cervical cancer been beaten?].
    Kimmig R
    MMW Fortschr Med; 2007 Mar; 149(12):28-9. PubMed ID: 17674886
    [No Abstract]   [Full Text] [Related]  

  • 28. Latin America. Price is the main barrier to wider use of papillomavirus vaccine.
    Kaiser J
    Science; 2008 May; 320(5878):860. PubMed ID: 18487164
    [No Abstract]   [Full Text] [Related]  

  • 29. Anticipating full benefits from the new papillomavirus vaccines.
    Griffiths PD
    Rev Med Virol; 2007; 17(1):1-3. PubMed ID: 17173349
    [No Abstract]   [Full Text] [Related]  

  • 30. HPV vaccine: implications for nurses and patients.
    Schmidt JV
    Nurs Womens Health; 2007 Feb; 11(1):83-7. PubMed ID: 17883822
    [No Abstract]   [Full Text] [Related]  

  • 31. Two doses and not three for the human papilloma virus vaccine in Chile.
    Bachelet VC
    Medwave; 2016 Jan; 16(1):e6373. PubMed ID: 26938044
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vaccines against human papillomavirus (HPV); between registration and implementation].
    van Rossum TG; de Melker HE; Houweling H; Voordouw AC; Meijer CJ; Helmerhorst TJ; Kretzschmar M; Berkhof J; van der Noordaa J
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):987-92. PubMed ID: 18549172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical cancer vaccine controversy in India.
    Das M
    Lancet Oncol; 2018 Feb; 19(2):e84. PubMed ID: 29413482
    [No Abstract]   [Full Text] [Related]  

  • 34. Introducing human papillomavirus vaccines into the health system in South Africa.
    Botha MH; Dochez C
    Vaccine; 2012 Sep; 30 Suppl 3():C28-34. PubMed ID: 22939017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current immunization committee includes vaccination against human papillomaviruses in the immunization schedule].
    Kinderkrankenschwester; 2007 May; 26(5):205. PubMed ID: 17550093
    [No Abstract]   [Full Text] [Related]  

  • 36. Just implementation of human papillomavirus vaccination.
    Malmqvist E; Natunen K; Lehtinen M; Helgesson G
    J Med Ethics; 2012 Apr; 38(4):247-9. PubMed ID: 22138726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new HPV vaccination.
    Bedford H
    Community Pract; 2008 Aug; 81(8):36-7. PubMed ID: 18834017
    [No Abstract]   [Full Text] [Related]  

  • 38. An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany.
    Largeron N; Petry KU; Jacob J; Bianic F; Anger D; Uhart M
    Expert Rev Pharmacoecon Outcomes Res; 2017 Feb; 17(1):85-98. PubMed ID: 27366939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus vaccine trials in India.
    Sengupta A; Shenoi A; Sarojini NB; Madhavi Y
    Lancet; 2011 Feb; 377(9767):719. PubMed ID: 21353902
    [No Abstract]   [Full Text] [Related]  

  • 40. [Insufficient basis for the inclusion of Human papillomavirus vaccination in the National Immunisation Programme in The Netherlands].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2001-4. PubMed ID: 18825885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.